RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-60
SponsorUniversity of Castilla-La Mancha
About this trial
The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are:
* Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients. * Compare the outcomes of Redcord treatment with standard care practices.
Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.
Eligibility criteria
Qualifiers
People diagnosed with Multiple Sclerosis according to McDonald's criteria.
EDSS less than 6 points.
Willingness to participate.
Disqualifiers
People with cognitive impairment, which makes it difficult to understand the questionnaires properly.
Pregnant women.
Severe psychological or psychiatric pathology diagnosed.
Trial design
Treatments tested in this trial
- Redcord
- Control (Standard treatment)
Treatment groups
76 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov